DiviDrip · VNDA

VNDA — Vanda Pharmaceuticals Inc.

VNDA is Vanda Pharmaceuticals Inc. (Healthcare) — a non-dividend-paying stock. Trading at $5.53. Market cap: $334M. Capital Quality Rank: 41/100 — Stagnant mediocrity.

Stock snapshot

Price$5.53
Market cap$334M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)41 / 100 · Stagnant mediocrity
ROIC (TTM)-48.5%
Revenue CAGR (3y)-5.3%
Shareholder buyback yield-1.33%
Altman Z-score zoneDistress

About VNDA

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Listed2006Employees533HQWashington, DCSectorHealthcareWebsitevandapharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside VNDA. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is VNDA's current stock price?

VNDA (Vanda Pharmaceuticals Inc.) is currently trading at $5.53.

Does VNDA pay a dividend?

VNDA (Vanda Pharmaceuticals Inc.) does not currently pay a regular dividend.

What is VNDA's Capital Quality Rank?

VNDA has a Capital Quality Rank of 41/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track VNDA in DiviDrip

Add VNDA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow